Tag: Laszlo Radvanyi

Ask a Cancer Researcher: How does a tumour’s genetics factor into cancer care?

July 5, 2024

Ask a Cancer Researcher: What is immunotherapy?

June 21, 2023

Standards redefined: What lab accreditation means to OICR Genomics

February 3, 2021

Imagining the next 20 years and planning for the next five

February 3, 2021

What we learned at the recent OICR-JLABS cell therapy symposium

February 3, 2021

A message from OICR’s President and Scientific Director, Dr. Laszlo Radvanyi

May 6, 2020

Unprecedented exploration generates most comprehensive map of cancer genomes charted to date

February 5, 2020

Researchers discover a new cancer-driving mutation in the “dark matter” of the cancer genome

October 9, 2019

Harnessing the time before a patient’s surgery to accelerate cancer research

September 20, 2019

Five fellows, four labs, three years, two countries, and a generous donation

July 3, 2019